Abstract
Unexplained signs and symptoms in an acute situation can be due to a metabolic derangement, which needs specific biochemical tests and emergency treatments. This is certainly the case in neonates and young children with an unexplained encephalopathy. Using basic tests a differential diagnosis can be made, followed by more specialized tests in blood and urine. It is extremely important to think of the different diagnostic possibilities, especially in case of metabolic acidosis, hypoglycemia, hyperammonemia, etc.
A second condition is when patients present with intractable seizures. Here also it is necessary to make the correct diagnosis and treatment.
Thirdly in case of acute ataxia some late-onset metabolic diseases should be in the differential diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zschocke J, Hoffman GJ. Vademecum Metabolicum. 3rd ed. Stuttgart: Schattauer; 2011.
Saudubray J-M. Clinical approach to inborn errors of metabolism in paediatrics. In: Saudubray J-M, van den Berghe G, Walter JH, editors. Inborn metabolic diseases. 5th ed. Heidelberg: Springer; 2012.
Fellman V, Kotarsky H. Mitochondrial hepatopathies in the newborn period. Semin Fetal Neonatal Med. 2011;16(4):222–8.
Bennett K, James C, Hussaun K. Pancreatic b-cell KATP channels: hypoglycemia and hyperglycaemia. Rev Endocr Metab Disord. 2010;11:157–63.
Bachmann C. Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr. 2003;162(6):410–6.
Nassogne MC, Héron B, Touati G, et al. Urea cycle defects: management and outcome. J Inherit Metab Dis. 2005;28(3):407–14.
Levrat V, Forest I, Fouilhoux A, et al. Carglumic acid: an additional therapy in the treatment of organic aciduris with hyperammonemia. Orphanet J Rare Dis. 2008;30(3):2.
Cor PB, Creer MH, Yamada KA, et al. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest. 1989;83:927–36.
Prasad AN, Hoffman GF. Early onset epilepsy and inherited metabolic disorders and management. Can J Neurol Sci. 2010;37:350–8.
Stockler S, Plecko B, Gospe Jr SM, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104(1–2):48–60.
Plecko B, Stockler S. Vitamin B6 dependent seizures. Can J Neurol Sci. 2009;36 Suppl 2:S73–7.
de Koning TJ, Klomp LW. Serine-deficiency syndromes. Curr Opin Neurol. 2004;17:197–204.
Wolf B. The neurology of biotinidase deficiency. Mol Genet Metab. 2011;104:27–34.
Leen WG, Klepper J, Verbeeck MM, et al. Glucose transporter-1 deficiency: the expanding clinical and genetic spectrum of a treatable disorder. Brain. 2010;133:655–70.
Klepper J, Leiendecker B. Glut 1 deficiency syndrome—2007 update. Dev Med Child Neurol. 2007;49:707–16.
Mastrangelo M, Leuzzi V. Genes of early-onset epileptic encephalopathies: from genotype to phenotype. Pediatr Neurol. 2012;46:24–31.
Milone M, Benarroch EE, Wong LJ. POLG-related -disorders: defects of the nuclear and mitochondrial genome interaction. Neurology. 2011;77:1847–52.
Sedel F, Lyon-Caen O, Saudubray JM. Therapy insight: inborn errors of metabolism in adult neurology—a clinical approach on treatable diseases. Nat Clin Pract Neurol. 2007;3:279–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
De Meirleir, L.J. (2014). Neurometabolic Crisis. In: Sejersen, T., Wang, C. (eds) Acute Pediatric Neurology. Springer, London. https://doi.org/10.1007/978-0-85729-491-3_9
Download citation
DOI: https://doi.org/10.1007/978-0-85729-491-3_9
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-490-6
Online ISBN: 978-0-85729-491-3
eBook Packages: MedicineMedicine (R0)